Direkt zum Inhalt
Merck

Fortfahren mit

1269254

USP

Famotidin-verwandte Verbindung E

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

N,N′′′-[Dithiobis-(methylen-4,2-thiazoldiyl)]-bisguanidin, 2,2′-[4,4′-Disulfandiylbis-(methylen)-bis-(thiazol-4,2-diyl)]-diguanidin

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis
25 mg
Warenkorb auf Verfügbarkeit prüfen
€ 1.380,00

Über diesen Artikel

Empirische Formel (Hill-System):
C10H14N8S4
CAS-Nummer:
Molekulargewicht:
374.53
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24

€ 1.380,00


Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


biological source

synthetic

grade

pharmaceutical primary standard

agency

USP

API family

famotidine

form

powder

packaging

pkg of 25 mg

manufacturer/tradename

USP

storage condition

protect from light

color

white

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

[s]1c(nc(c1)CSSCc2nc([s]c2)N=C(N)N)N=C(N)N

InChI

1S/C10H14N8S4/c11-7(12)17-9-15-5(1-19-9)3-21-22-4-6-2-20-10(16-6)18-8(13)14/h1-2H,3-4H2,(H4,11,12,15,17)(H4,13,14,16,18)

InChI key

ZWHJVLVEEDAPHN-UHFFFAOYSA-N

General description

Famotidine Related Compound E (Famotidine Impurity E) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Famotidine Related Compound E can be used as a pharmaceutical primary standard for the determination of the analyte in pharmaceutical formulations by various analytical techniques.
Also, for use with USP monograph such as Famotidine

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
PHR2911PHR2912PHR2908
grade

pharmaceutical primary standard

grade

certified reference material, pharmaceutical secondary standard

grade

pharmaceutical secondary standard, reference material

grade

certified reference material, pharmaceutical secondary standard

manufacturer/tradename

USP

manufacturer/tradename

-

manufacturer/tradename

-

manufacturer/tradename

-

format

neat

format

-

format

-

format

-

form

powder

form

-

form

-

form

solid

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical

application(s)

pharmaceutical small molecule

application(s)

pharmaceutical small molecule

biological source

synthetic

biological source

-

biological source

-

biological source

-


Still not finding the right product?

Explore all of our products under Famotidin-verwandte Verbindung E


Lagerklasse

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Famotidine
Pharmacopeia, US
United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020)
RP-HPLC determination of famotidine and its potential impurities in pharmaceuticals
Helali N, et al.
Chromatographia, 60(7-8) (2004)
Potentiometric determination of famotidine in pharmaceutical formulations
Ayad MM, et al.
Journal of Pharmaceutical and Biomedical Analysis, 29(1-2) (2002)



Global Trade Item Number

SKUGTIN
1269254-25MG04061833830246

Questions

Reviews

No rating value

Active Filters